The importance of quality-of-life endpoints in clinical trials to the practicing oncologist

Citation
Sd. Passik et Kl. Kirsh, The importance of quality-of-life endpoints in clinical trials to the practicing oncologist, HEMAT ONCOL, 14(4), 2000, pp. 877
Citations number
29
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
ISSN journal
08898588 → ACNP
Volume
14
Issue
4
Year of publication
2000
Database
ISI
SICI code
0889-8588(200008)14:4<877:TIOQEI>2.0.ZU;2-Q
Abstract
Quality-of-life research has helped to describe and draw attention to the h uman side of cancer treatment. The practicing oncologist can learn a great deal by keeping abreast of developments in this field and using these findi ngs in treatment decision making. This article traces the change in the can cer disease experience as a context for understanding the importance of qua lity-of-life research. The history of quality-of-life research and measurem ent is examined, and this information is integrated into a practical discus sion of physician-patient communication.